12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Chiromics, Kadmon deal

Kadmon received non-exclusive rights to use Chiromics' chemical compound libraries to discover and develop pharmaceutical...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >